Wordt geladen...
The influence of subclonal resistance mutations on targeted cancer therapy
Clinical oncology is being revolutionized by the increasing use of molecularly targeted therapies. This paradigm holds great promise for improving cancer treatment; however, allocating specific therapies to the patients who are most likely to derive a durable benefit continues to represent a conside...
Bewaard in:
| Gepubliceerd in: | Nat Rev Clin Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4838548/ https://ncbi.nlm.nih.gov/pubmed/26483300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2015.175 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|